Journal article
Predictors of Quality of Life Improvement with Escitalopram and Adjunctive Aripiprazole in Patients with Major Depressive Disorder: A CAN-BIND Study Report
Abstract
BackgroundNon-response to first-line treatment for major depressive disorder (MDD) is common; for such individuals, quality of life (QoL) impairments can be severe. Identifying predictors of QoL changes may support the management of cases with persistent depressive symptoms despite adequate initial pharmacological/psychological treatment.ObjectiveThe present study aimed to explore predictors of domain-specific QoL improvement following …
Authors
Morton E; Bhat V; Giacobbe P; Lou W; Michalak EE; McInerney S; Chakrabarty T; Frey BN; Milev RV; Müller DJ
Journal
CNS Drugs, Vol. 35, No. 4, pp. 439–450
Publisher
Springer Nature
Publication Date
April 2021
DOI
10.1007/s40263-021-00803-2
ISSN
1172-7047